Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen. About ...

Thousands of bottles of blood-pressure medicine are being recalled after the Food and Drug Administration said trace amounts of potential carcinogens were found to be in the medicine. Camber ...

More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Since ...

(NBC) — Thousands of bottles of a prescription medicine for treating high blood pressure and congestive heart failure have been recalled over the detection of trace amounts of a possible carcinogen.

This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty ...

A randomized, double-blind, placebo-controlled, parallel-group multicenter study was conducted to evaluate the antihypertensive efficacy and safety of 8-week treatment with one of three fixed-dose ...

These are the results of a new study, which included hypertensive patients with diabetes mellitus and overt nephropathy, presented here this week at the American Society of Hypertension 2007 ...

Aurobindo Pharma USA has recalled 80 lots of medicines containing valsartan because of the presence of the probable carcinogen N-nitrosodiethylamine (NDEA), marking the latest recall of tainted ...

COMMACK, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...

Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the renin–angiotensin system slows the progression of renal disease in patients with type 1 diabetes, but similar ...